Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance

Ayala Luria, Ahmed Bettaieb, Yannan Xi, Guang Jong Shieh, Hsin Chen Liu, Hiromi Inoue, Hsing Ju Tsai, John D. Imig, Fawaz Haj, Bruce D. Hammock

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Visceral obesity has been defined as an important element of the metabolic syndrome and contributes to the development of insulin resistance and cardiovascular disease. Increasing endogenous levels of epoxyeicosatrienoic acids (EETs) are known for their analgesic, antihypertensive, and antiinflammatory effects. The availability of EETs is limited primarily by the soluble epoxide hydrolase (sEH, EPHX2), which metabolizes EETs to their less active diols. In this study, we tested the hypothesis that EETs are involved in glucose regulation and in retarding the development of insulin resistance. To address the role of EETs in regulating glucose homeostasis and insulin signaling, we used mice with targeted gene deletion of sEH (Ephx2-null mice) and a subsequent study with a selective sEH inhibitor. When wild-type mice are fed a high fat diet, insulin resistance develops. However, knockout or inhibition of sEH activity resulted in a significant decrease in plasma glucose. These findings are characterized by enhancement of tyrosyl phosphorylation of the insulin receptor, insulin receptor substrate 1, and their downstream cascade. In addition, pancreatic islets were larger when sEH was disrupted. This effect was associated with an increase in vasculature. These observations were supported by pharmacological inhibition of sEH. These data suggest that an increase in EETs due to sEH-gene knockout leads to an increase in the size of islets and improved insulin signaling and sensitivity.

Original languageEnglish (US)
Pages (from-to)9038-9043
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number22
DOIs
StatePublished - May 31 2011

Fingerprint

Epoxide Hydrolases
Islets of Langerhans
Insulin Resistance
Homeostasis
Glucose
Insulin Receptor Substrate Proteins
Gene Knockout Techniques
Abdominal Obesity
Insulin Receptor
Gene Deletion
High Fat Diet
Antihypertensive Agents
Analgesics
Anti-Inflammatory Agents
Cardiovascular Diseases
Phosphorylation
Pharmacology
Insulin
Acids

Keywords

  • Arachidonic acid pathway
  • Pancreas
  • Type 2 diabetes

ASJC Scopus subject areas

  • General

Cite this

Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. / Luria, Ayala; Bettaieb, Ahmed; Xi, Yannan; Shieh, Guang Jong; Liu, Hsin Chen; Inoue, Hiromi; Tsai, Hsing Ju; Imig, John D.; Haj, Fawaz; Hammock, Bruce D.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, No. 22, 31.05.2011, p. 9038-9043.

Research output: Contribution to journalArticle

Luria, Ayala ; Bettaieb, Ahmed ; Xi, Yannan ; Shieh, Guang Jong ; Liu, Hsin Chen ; Inoue, Hiromi ; Tsai, Hsing Ju ; Imig, John D. ; Haj, Fawaz ; Hammock, Bruce D. / Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. In: Proceedings of the National Academy of Sciences of the United States of America. 2011 ; Vol. 108, No. 22. pp. 9038-9043.
@article{46b24479b9c6497a84f8d2e97bd8d2ee,
title = "Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance",
abstract = "Visceral obesity has been defined as an important element of the metabolic syndrome and contributes to the development of insulin resistance and cardiovascular disease. Increasing endogenous levels of epoxyeicosatrienoic acids (EETs) are known for their analgesic, antihypertensive, and antiinflammatory effects. The availability of EETs is limited primarily by the soluble epoxide hydrolase (sEH, EPHX2), which metabolizes EETs to their less active diols. In this study, we tested the hypothesis that EETs are involved in glucose regulation and in retarding the development of insulin resistance. To address the role of EETs in regulating glucose homeostasis and insulin signaling, we used mice with targeted gene deletion of sEH (Ephx2-null mice) and a subsequent study with a selective sEH inhibitor. When wild-type mice are fed a high fat diet, insulin resistance develops. However, knockout or inhibition of sEH activity resulted in a significant decrease in plasma glucose. These findings are characterized by enhancement of tyrosyl phosphorylation of the insulin receptor, insulin receptor substrate 1, and their downstream cascade. In addition, pancreatic islets were larger when sEH was disrupted. This effect was associated with an increase in vasculature. These observations were supported by pharmacological inhibition of sEH. These data suggest that an increase in EETs due to sEH-gene knockout leads to an increase in the size of islets and improved insulin signaling and sensitivity.",
keywords = "Arachidonic acid pathway, Pancreas, Type 2 diabetes",
author = "Ayala Luria and Ahmed Bettaieb and Yannan Xi and Shieh, {Guang Jong} and Liu, {Hsin Chen} and Hiromi Inoue and Tsai, {Hsing Ju} and Imig, {John D.} and Fawaz Haj and Hammock, {Bruce D.}",
year = "2011",
month = "5",
day = "31",
doi = "10.1073/pnas.1103482108",
language = "English (US)",
volume = "108",
pages = "9038--9043",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "22",

}

TY - JOUR

T1 - Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance

AU - Luria, Ayala

AU - Bettaieb, Ahmed

AU - Xi, Yannan

AU - Shieh, Guang Jong

AU - Liu, Hsin Chen

AU - Inoue, Hiromi

AU - Tsai, Hsing Ju

AU - Imig, John D.

AU - Haj, Fawaz

AU - Hammock, Bruce D.

PY - 2011/5/31

Y1 - 2011/5/31

N2 - Visceral obesity has been defined as an important element of the metabolic syndrome and contributes to the development of insulin resistance and cardiovascular disease. Increasing endogenous levels of epoxyeicosatrienoic acids (EETs) are known for their analgesic, antihypertensive, and antiinflammatory effects. The availability of EETs is limited primarily by the soluble epoxide hydrolase (sEH, EPHX2), which metabolizes EETs to their less active diols. In this study, we tested the hypothesis that EETs are involved in glucose regulation and in retarding the development of insulin resistance. To address the role of EETs in regulating glucose homeostasis and insulin signaling, we used mice with targeted gene deletion of sEH (Ephx2-null mice) and a subsequent study with a selective sEH inhibitor. When wild-type mice are fed a high fat diet, insulin resistance develops. However, knockout or inhibition of sEH activity resulted in a significant decrease in plasma glucose. These findings are characterized by enhancement of tyrosyl phosphorylation of the insulin receptor, insulin receptor substrate 1, and their downstream cascade. In addition, pancreatic islets were larger when sEH was disrupted. This effect was associated with an increase in vasculature. These observations were supported by pharmacological inhibition of sEH. These data suggest that an increase in EETs due to sEH-gene knockout leads to an increase in the size of islets and improved insulin signaling and sensitivity.

AB - Visceral obesity has been defined as an important element of the metabolic syndrome and contributes to the development of insulin resistance and cardiovascular disease. Increasing endogenous levels of epoxyeicosatrienoic acids (EETs) are known for their analgesic, antihypertensive, and antiinflammatory effects. The availability of EETs is limited primarily by the soluble epoxide hydrolase (sEH, EPHX2), which metabolizes EETs to their less active diols. In this study, we tested the hypothesis that EETs are involved in glucose regulation and in retarding the development of insulin resistance. To address the role of EETs in regulating glucose homeostasis and insulin signaling, we used mice with targeted gene deletion of sEH (Ephx2-null mice) and a subsequent study with a selective sEH inhibitor. When wild-type mice are fed a high fat diet, insulin resistance develops. However, knockout or inhibition of sEH activity resulted in a significant decrease in plasma glucose. These findings are characterized by enhancement of tyrosyl phosphorylation of the insulin receptor, insulin receptor substrate 1, and their downstream cascade. In addition, pancreatic islets were larger when sEH was disrupted. This effect was associated with an increase in vasculature. These observations were supported by pharmacological inhibition of sEH. These data suggest that an increase in EETs due to sEH-gene knockout leads to an increase in the size of islets and improved insulin signaling and sensitivity.

KW - Arachidonic acid pathway

KW - Pancreas

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=79959351596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959351596&partnerID=8YFLogxK

U2 - 10.1073/pnas.1103482108

DO - 10.1073/pnas.1103482108

M3 - Article

VL - 108

SP - 9038

EP - 9043

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 22

ER -